The World Health Organization (WHO) announced the following to support countries and technical institutions to strengthen the detection of TB. A person who integrates guidelines for tuberculosis. Module 3: Diagnosis today. Compared to the previous version published in 2024, this guideline is as follows.
- WHO policy guidelines for diagnosis of tuberculosis infections, diseases and drug resistance are coupled to a single reference document
- It offers new recommendations for the simultaneous test of respiratory and non-voluntary samples between children without HIV and HIV or children who are unknown HIV.
- Establish two new class TB diagnostic technologies for the initial detection of TB and resistance to resistance
- WHO TB Diagnosis Class Determination and Product Evaluation Determination and Overview.
WHO operating handbook for tuberculosis. Module 3: Diagnosis comes with integrated guidelines. The WHO Operation Handbook provides detailed guidelines for implementing WHO evidence as well as laboratory staff, clinical and other clinical employees. The update of the companion handbook is integrated with the integration of instructions for TB infections, diagnosis and drug resistance tests, new diagnostic classes and simultaneous test strategies, consideration of simultaneous test strategies, new or updated interferon gamma release analysis for detection of TB infections This includes a presentation of policy statements for solutions. Such classes and product developments follow the steps of the steps and processes needed to implement and expand new tests on TB detection.
Major changes in this update
- Two new classes of TB diagnostic tests have been established for the initial detection of TB and resistance to the resistance to the ripfamin. This class has a different procedure and test result automation level and includes tests recommended as a standalone product. The new low complex automated nucleic acid amplification test (LC-NAAT) classes include the Xpert® MTB/ RIF and Xpert MTB/ RIF Ultra Assays and Truenat® MTB Plus and MTB-RIF DX Assay. The Low Complexity Manual Nucleic acid amplification test (LC-MNAAT) class includes LOOPAMPTM MTBC Detection Kit (TB LAMP) (EIKEN Chemical). This new class -based recommendation replaces the recommendations for each previous product.
- Respiratory and non-voluntary samples of the initial detection of TB and resistance to resistance to the resistance to the resistance of the TB are recommended for adults with HIV, children with HIVs, children without HIVs, or children without HIV. Practical guidelines for policy guidelines for policy guidelines for testing on TB infections have been added.
- Description of TB Diagnosis Test Determination and TB Diagnostic Products Prior Route by someone added to the background section.
- The TB Diagnosis Test Class Description Table has been modified to match the class determination criteria in the background section.
- Four old web appendices dealing with systematic review and the Guideline Development Group (GDG) evidence have integrated the evidence of the policy update into two webs. Web Annex A includes evidence (ETD) table and web appendix B for systematic review, recommendation rating, development and evaluation (Grade) table and decisions. Both web parts now present content for each TB diagnostic class.
